BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2014
View Archived Issues
NKTT-320 activates immunostimulatory functions of human iNKTs
Read More
RP-5063 shows robust efficacy and safety in phase II REFRESH trial
Read More
Roche and NCI present preclinical data for RG-7787
Read More
New grant to support phase I/II trial of OXB-102 gene therapy for Parkinson's disease
Read More
RXi enrolls first patient in phase IIa keloid scar trial
Read More
Lilly nociceptin receptor antagonist proves useful for various conditions
Read More
MEI Pharma presents novel PI3Kdelta inhibitors
Read More
Vertex Pharmaceuticals synthesizes novel mannose derivatives
Read More
Advinus Therapeutics prepares novel DGAT1 inhibitors for diabetes and other disorders
Read More
InterMune selects new agents for fibrotic disorders
Read More
Allena Pharmaceuticals reports phase I data for ALLN-177
Read More
Akers Biosciences begins trials for Chlamydia assay
Read More
Vizamyl to be launched in U.S. in late 2Q 2014
Read More
Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing
Read More
Sotatercept obtains FDA orphan drug designation
Read More
Silence Therapeutics shows gene knockdown in non-human primates
Read More
Parion Sciences regains rights to ENaC inhibitors
Read More
First patient dosed in phase III study of Pulmaquin in non-cystic fibrosis bronchiectasis
Read More
Phase III program for mepolizumab in COPD begins
Read More
Favorable pharmacokinetics and pharmacodynamic activity of RPC-1063 in human volunteers
Read More
AstraZeneca offers overview of first quarter 2014
Read More
Forest Laboratories to acquire Furiex Pharmaceuticals
Read More
Ono and Nissan Chemical discontinue license agreement
Read More
FDA issues complete response letter regarding cangrelor NDA
Read More
GSK's inhaled umeclidinium approved in U.S.
Read More